✦ LIBER ✦

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

✍ Scribed by Catalano, G; Comella, P; Casaretti, R; Crucitta, E; De Vita, F; Palmeri, S; Avallone, A; Orditura, M; De Lucia, L; Del Prete, S

Book ID: 109997301
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 86 KB
Volume: 86
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion fluorouracil/leucovo

Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer

✍ John A. Conti; Nancy E. Kemeny; Leonard B. Saltz; A. McKenzie André; Dennis D. G 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

A randomized phase II study to compare o

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

✍ Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 294 KB

Randomised trial comparing biweekly oxal

Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401

✍ Pasquale Comella; Bruno Massidda; Gianfranco Filippelli; Antonio Farris; Donato 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 475 KB

Irinotecan plus leucovorin-modulated 5-f

Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

✍ Comella, P; Farris, A; Lorusso, V; Palmeri, S; Maiorino, L; Lucia, L De; Buzzi, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

Oxaliplatin added to the simplified bimo

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

✍ F Maindrault-Goebel; C Louvet; T André; E Carola; J.P Lotz; J.L Molitor; M.L Gar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Severe enteropathy among patients with s

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis

✍ J. Philip Kuebler; Linda Colangelo; Michael J. O'Connell; Roy E. Smith; Greg Yot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## BACKGROUND. Cases of severe gastrointestinal toxicity were monitored prospectively during NSABP C‐07, a randomized clinical trial of adjuvant therapy for patients with stage II/III colon cancer. ## METHODS. Patients were treated with weekly bolus 5‐fluorouracil (5‐FU) and leucovor